The Effect of Yoga and Stabilization Exercises in Individuals With Chronic Low Back Pain
19 ottobre 2021 aggiornato da: Ozlem Ulger, Hacettepe University
The Effect of Yoga and Stabilization Exercises on Pain, Functional Status, Metabolic Capacity and Sleep Quality in Individuals With Chronic Low Back Pain: A Randomized, Crossover Study.
Although exercise has been shown to be effective in low back pain in the literature, there is no conclusion about which exercise is superior to the other.
Although there are studies showing positive effects of spinal stabilization exercises and yoga approach on pain level, disability level and quality of life in patients with chronic low back pain, studies evaluating the effectiveness in many other aspects are insufficient.
Therefore, this study aimed to investigate the effects of spinal stabilization and yoga exercises on pain, functional status, metabolic capacity, kinesophobia and sleep quality in patients with chronic low back pain.
Panoramica dello studio
Stato
Completato
Condizioni
Intervento / Trattamento
Tipo di studio
Interventistico
Iscrizione (Effettivo)
28
Fase
- Non applicabile
Contatti e Sedi
Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.
Luoghi di studio
-
-
Altındağ
-
Ankara, Altındağ, Tacchino, 06100
- Özlem Ülger
-
-
Criteri di partecipazione
I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.
Criteri di ammissibilità
Età idonea allo studio
Da 25 anni a 65 anni (Adulto, Adulto più anziano)
Accetta volontari sani
No
Sessi ammissibili allo studio
Tutto
Descrizione
Inclusion Criteria:
- Chronic non-specific low back pain diagnosis
- Having pain that persists for at least 12 weeks
- 25-65 age range
Exclusion Criteria:
- Scoliosis with a cobb angle of more than 20º
- History of previous surgery for the lumbal region
- Having an additional diagnosis such as spondylolisthesis, spinal stenosis, spondylolysis
- Presence of neurological deficits
- Metastatic state presence
- Presence of neurological deficits due to diabetes
- Presence of metabolic problems such as thyroid, hypertension, coronary artery disease
- The presence of inflammatory problems involving the spine
Piano di studio
Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione incrociata
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: Yoga Group
The sessions will begin with breathing exercises in standing, sitting, supine and prone positions, and these exercises will be applied for about 10 minutes.
After the breathing exercises, the sudden relaxation technique, which will take 2-3 minutes, firstly contracting the whole body from the feet to the head and then completely relaxing it.
|
Yoga
|
|
Sperimentale: Spinal Stabilization Exercise Group
Spinal stabilization exercises will be applied to the individuals in this group for 8 weeks / 2 days a week, approximately 50-60 minutes a day under the supervision of a physiotherapist. Spinal stabilization exercises will be progressed in 3 phases by gradually increasing the difficulty. |
Spinal Stabilization Exercise
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Pain Intensity
Lasso di tempo: 15 minutes, through study completion, an average of 8 weeks, Change from pain intensity
|
Pain intensity of participants will be evaluated with visual analog scale (VAS).
Paricipants asked to mark the intensity of pain on a 10 cm long line, explaining that the leftmost of the line does not have pain, that the pain increases while moving to the right, and that the pain is unbearable on the far right.
VAS scored between 0-10 cm.
|
15 minutes, through study completion, an average of 8 weeks, Change from pain intensity
|
|
Disability Severity
Lasso di tempo: 5 minutes, through study completion, an average of 8 weeks, Change from disability
|
Patient's pain related functional status will be measured by Oswestry Disability Index. The scale is considered the 'gold standard' of low back functional outcome tools. This scale contain questions related to functional activities of pain intensity, personal care, lifting, walking, sitting, standing, sleeping, sex life, social life and travelling. Interpretation of scale are 0% to 20% for minimal disability, 21% to 40% for moderate disability, 41 % to 60 % for severe disability 61% to 80 % for crippled and 81 % to 100 % Bed-bound. The Oswestry Disability Index is scored between 0-50 points. An increase in score indicates a poor result. Patient's back-related functional performance will be evaluated with Back Performance Scale. Each question is scored between 0 and 3. The total score recorded. The Back Performance Scale test is scored between 0-15 points. An increase in score indicates a poor result. |
5 minutes, through study completion, an average of 8 weeks, Change from disability
|
|
Funcitonal Performance
Lasso di tempo: 10 minutes, through study completion, an average of 8 weeks, Change from Functional status and performance
|
Patient's back-related functional performance will be evaluated with Back Performance Scale.
Each question is scored between 0 and 3.
The total score recorded.
The Back Performance Scale test is scored between 0-15 points.
An increase in score indicates a poor result.
|
10 minutes, through study completion, an average of 8 weeks, Change from Functional status and performance
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Deep muscle activation
Lasso di tempo: 5 minutes, through study completion, an average of 8 weeks, Change from deep muscle activation
|
To evaluate the transversus abdominis muscle activation, the stabilizer biofeedback device is placed under the abdomen, just below the spina iliaca anterior superior, while the patient is in the prone position.
The cuff of the device is inflated to 70 mmHg, the patient is asked to breathe and pull the abdomen up and in while exhaling, but the patient is warned not to make pelvis and spine movement.
In the meantime, how much the pressure has changed is observed from the stabilizer device.
In the test, the average of 3 repetitions will be recorded.
With successful measurement, the pressure is expected to drop between 6 and 10 mm-Hg.
|
5 minutes, through study completion, an average of 8 weeks, Change from deep muscle activation
|
|
Kinesiophobia
Lasso di tempo: 5 minutes, through study completion, an average of 8 weeks, Change from kinesiophobia
|
Fear-Avoidance-Beliefs Questionnaire will be applied to evaluate kinesiophobia which is fear of movement due to low back pain.
This questionnaire has 2 sub-sections related to physical activity and work.
There are 4 questions scored in the physical activity section and 7 questions in the work section.
0-6 points are obtained for each question.
The total score will be recorded.
Physical Activity sub-section scored between 0-24 points.
Work sub-sections scored between 0-42 points.
The higher the score, the higher the kinesiophobia.
|
5 minutes, through study completion, an average of 8 weeks, Change from kinesiophobia
|
|
Sleep quality
Lasso di tempo: 5 minutes, through study completion, an average of 8 weeks, Change from Baseline sleep quality
|
The Pittsburg Sleep Quality Index will be used to evaluate sleep quality.
This questionnaire evaluates sleep quality and disturbance over the past month.
The scale consists of 7 subcomponents: Subjective Sleep Quality, Sleep Latency, Sleep Duration, Habitual Sleep Efficiency, Sleep Disturbances, Use of Sleeping Medication, and Daytime Dysfunction.
Each component is scored between 0-3 points.
The total score of the 7 components gives the total score of the scale.
The total score ranges from 0-21.
A total score greater than 5 indicates "poor sleep quality".
|
5 minutes, through study completion, an average of 8 weeks, Change from Baseline sleep quality
|
|
Metabolic Capacity
Lasso di tempo: 15 minutes, through study completion, an average of 8 weeks, Change from Baseline metabolic capacity.
|
Metabolic capacity evaluation will be performed according to 6 Minute Walk Test.
Individuals are asked to walk as fast as possible for 6 minutes without running on the 30 m long corridor.
The test is started, the number of rounds is recorded while the patient is walking.
Heart rate, blood pressure, oxygen saturation and respiratory frequency will be evaluated and recorded at first, at the end of the test and one minute after.
Walking distance is recorded in meters.
|
15 minutes, through study completion, an average of 8 weeks, Change from Baseline metabolic capacity.
|
Collaboratori e investigatori
Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.
Sponsor
Investigatori
- Investigatore principale: Ozlem Ulger, Prof, Hacettepe University
Studiare le date dei record
Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.
Studia le date principali
Inizio studio (Effettivo)
15 febbraio 2021
Completamento primario (Effettivo)
15 agosto 2021
Completamento dello studio (Effettivo)
15 agosto 2021
Date di iscrizione allo studio
Primo inviato
8 febbraio 2021
Primo inviato che soddisfa i criteri di controllo qualità
5 marzo 2021
Primo Inserito (Effettivo)
8 marzo 2021
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
20 ottobre 2021
Ultimo aggiornamento inviato che soddisfa i criteri QC
19 ottobre 2021
Ultimo verificato
1 ottobre 2021
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- KA-20031
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
NO
Descrizione del piano IPD
No.
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
No
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
No
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .